Skip to main content
Premium Trial:

Request an Annual Quote

Tripos and Elsevier to Integrate Informatics Platforms

NEW YORK, Aug. 10 (GenomeWeb News) - Tripos and Elsevier MDL today said they plan to integrate their informatics platforms.


The two companies will now work to integrate the work-flow capabilities between Elsevier's MDL Isentris technology and Trips' Benchware suite of laboratory informatics software.


Under the terms of the agreement Tripos will now be a strategic member of the MDL Isentris Alliance, and Elsevier MDL will join the Tripos Alliance Program as a global strategic partner, the firms said.


Elsevier MDL CEO Lars Barfod said the alliance would facilitate "the integration of data and workflow between our products -- which is something that customers have been asking for."


Financial details were not disclosed.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.